How can Signal Genetics help patients with myeloma?

When diagnosed with myeloma, patients often want to know how the disease will affect them and what the best treatment options are. Signal Genetics' patented MyPRS Plus™ analyzes the patient’s unique Gene Expression Profile (GEP) ‘signature’ and delivers a personalized answer on the patient's disease that helps physicians select the best treatment. Talk to your doctor to see if MyPRS Plus is right for you.
